IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

Kevin C. Conlon(Tallaght University Hospital), Thomas A. Waldmann(Cancer Institute (WIA)), Michael Petrus(Center for Cancer Research), Jennifer L. Hsu(The University of Texas MD Anderson Cancer Center), Cody J. Peer(National Institutes of Health), E. Lake Potter(National Institute of Allergy and Infectious Diseases), Bonita R. Bryant(Bryan College), Jason L. Yovandich(Bryan College), Liyanage P. Perera(Bryan College), Stephen P. Creekmore(Bryan College), Joanna H. Shih(University of Minnesota), Sigrid Dubois(Bryan College), William D. Figg(National Cancer Institute), Miloš D. Miljković(Tufts University), Mario Roederer(National Institutes of Health), Chyi‐Chia Richard Lee(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Thomas A. Fleisher(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Stefania Pittaluga(New York University)
Clinical Cancer Research
May 29, 2019
Cited by 134


Related Papers